Baupost Group - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baupost Group ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$9,575,000
-23.6%
22,268,3990.0%0.13%
-28.2%
Q1 2016$12,530,000
+221.1%
22,268,399
+881.7%
0.18%
+154.9%
Q4 2015$3,902,000
+155.2%
2,268,399
+176.2%
0.07%
+184.0%
Q3 2015$1,529,000821,3630.02%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 5,427,559$2,334,0001.60%
Scale Management, LLC 1,312,575$564,0001.34%
Foresite Capital Management III, LLC 2,542,575$1,093,0000.75%
BVF INC/IL 5,252,100$2,258,0000.48%
TIVERTON ASSET MANAGEMENT LLC 45,313$4,261,0000.18%
Baupost Group 22,268,399$9,575,0000.13%
Rhenman & Partners Asset Management AB 1,200,000$516,0000.09%
NEA Management Company, LLC 370,900$1,595,0000.08%
SAMLYN CAPITAL, LLC 6,160,417$2,649,0000.06%
Palo Alto Investors LP 1,673,024$719,0000.05%
View complete list of OREXIGEN THERAPEUTICS INC shareholders